MarketBeat's Top 5 Stock Picks - Just Released
MarketBeat has just released five new trading ideas, but Tesla, Apple, and Netflix didn't make the cut. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. Now, MarketBeat thinks these five stocks may be even better buys.
View the Stocks Here
Claudia Ibarra, insider at DermTech

Claudia Ibarra Insider Information

COO of DermTech
Claudia Ibarra has over 25 years of experience in clinical laboratory operations, in the areas of oncology, immunology and molecular biology. In her leadership roles, she grew and developed the laboratory operations of renowned diagnostic companies to a highly efficient and successful state, with unparalleled quality, service level and inspection track records. Before joining DermTech, Mrs. Ibarra served as Senior Vice President, Laboratory Operations at Exagen, Director of the molecular oncology laboratory at Genoptix, Inc., where she was also the Molecular Genetic Training Program Coordinator, and other reference clinical laboratories focused on immunology and solid tumors. Mrs. Ibarra holds a degree in Biochemistry with specialization in clinical laboratory science from the University of Buenos Aires, Argentina and a California License as Clinical Laboratory Scientist.

What is Claudia Ibarra's net worth?

The estimated net worth of Claudia Ibarra is at least $4.05 million as of June 8th, 2021. Ms. Ibarra owns 118,510 shares of DermTech stock worth more than $4,050,672 as of September 26th. This net worth evaluation does not reflect any other investments that Ms. Ibarra may own. Learn More.

What is Claudia Ibarra's salary?

As the COO of DermTech, Inc., Ms. Ibarra earned a total compensation package of $2,062,809.00 in 2020. Ms. Ibarra earned a salary of $285,000.00, stock awards of $1,480,166.00, options awards of $232,248.00, non-equity compensation of $64,838.00, and other compensation of $557.00.

How do I contact Claudia Ibarra?

The corporate mailing address for Ms. Ibarra and other DermTech executives is 11099 N. Torrey Pines Road Suite 100, La Jolla CA, 92037. DermTech can also be reached via phone at (858) 450-4222 and via email at [email protected]

Has Claudia Ibarra been buying or selling shares of DermTech?

During the last quarter, Claudia Ibarra has sold $125,802.00 in shares of DermTech stock. Most recently, Claudia Ibarra sold 457 shares of the business's stock in a transaction on Monday, September 13th. The shares were sold at an average price of $36.19, for a transaction totalling $16,538.83.

Who are DermTech's active insiders?

DermTech's insider roster includes John Dobak (CEO), Claudia Ibarra (COO), Scott Pancoast (Director), Enrico Picozza (Director), Kevin Sun (CFO), and Todd Wood (Insider).

Are insiders buying or selling shares of DermTech?

In the last year, DermTech insiders bought shares 3 times. They purchased a total of 433,898 shares worth mmore than $9,943,991.00. In the last year, insiders at the sold shares 39 times. They sold a total of 300,021 shares worth mmore than $11,647,331.39. The most recent insider tranaction occured on September, 13th when Todd Michael Wood Insider bought 1,126 shares worth more than $40,749.94. Insiders at DermTech own 8.0 % of the company.

Information on this page was last updated on 9/13/2021.

Claudia Ibarra Insider Trading History at DermTech

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/13/2021Sell457$36.19$16,538.83View SEC Filing Icon  
9/8/2021Sell3,020$36.18$109,263.60View SEC Filing Icon  
6/8/2021Sell2,405$43.43$104,449.15118,510View SEC Filing Icon  
3/8/2021Sell2,431$50.04$121,647.24View SEC Filing Icon  
12/8/2020Sell2,421$11.86$28,713.06115,246View SEC Filing Icon  
9/10/2020Sell7,605$10.82$82,286.10120,470View SEC Filing Icon  
See Full Table

Claudia Ibarra Buying and Selling Activity at DermTech

This chart shows Claudia Ibarra's buying and selling at DermTech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

DermTech Company Overview

DermTech logo
DermTech, Inc. is a genomics company in dermatology, which engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate the early detection of skin cancers, assesses inflammatory diseases, and customizes drug treatments. Its products include adhesive skin collection kit, pigmented lesion assay, nevome, and carcinome. The company was founded in 1995 and is headquartered in La Jolla, CA.
Read More

Today's Range

Now: $34.18
Low: $34.17
High: $35.84

50 Day Range

MA: $35.24
Low: $32.16
High: $38.45

2 Week Range

Now: $34.18
Low: $9.85
High: $84.49


261,616 shs

Average Volume

334,832 shs

Market Capitalization

$1.01 billion

P/E Ratio


Dividend Yield



The $7 Secret to $1,000 in Upfront Payouts
Extract $500... $1,000... even $1,500 in upfront payments from some of the market's hottest blue chip companies... without buying a single option.

It's unlike anything you've seen before, and it's never been more affordable to get started.
Click here for details.